Tests stem cells from umbilical cord or placenta for polycystic ovary syndrome
Tests donor stem cells given into a vein in adults with polycystic ovary syndrome.
Key facts
- Who runs it
- The Foundation for Orthopaedics and Regenerative Medicine
- Where
- Naples, United StatesSee the siteAlso in 1 other country, 1 site
- Trial code
- Registry title
- Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for PCOS
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 20 people, planned
- Started
- 16 Nov 2023
- Expected to end
- 16 Nov 2027
- Type of study
- Interventional
- Treatments tested
- Cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells
- Record updated
- 20 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 or older with polycystic ovary syndrome (PCOS) shown on an ultrasound. It tests stem cells given through a vein.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- Polycystic ovary syndrome shown on an ultrasound
- Earlier treatment
- Not stated in the record. People with a previous organ transplant cannot join.
Main reasons for not taking part
- Active infection
- Active cancer
- Chronic failure of several organs
- Pregnancy
- Previous organ transplant
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Ultrasound documented poly cystic ovary syndrome
Who cannot take part
- Continued drug abuse
- Previous organ transplant
- Active infection
- Active cancer
- Chronic multisystem organ failure
- Medical condition that would (based on the opinion of the investigator) compromise patient's safety
- Hypersensitivity to sulfur
- Clinically significant abnormalities on pre-treatment laboratory evaluation
- Pregnancy
- Inability to supply proper informed consent
Where in United States
Also in 1 other country, 1 site
- Prodromos Stem Cell InstituteNaples, United StatesContact: Chadwick Prodromos, MDTaking people
About the trial
What the trial wants to find out
This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells delivered intravenously for the treatment of Polycystic Ovary Syndrome.
The group in the trial
- Treatment GroupTreatment being tested
Intravenous infusion
Treatment: Cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for the Treatment of Polycystic Ovary Syndrome
- Plain-language title
- Tests stem cells from umbilical cord or placenta for polycystic ovary syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 20 October 2026